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Graft infection after endovascular abdominal aortic
aneurysm repair
Adriana Laser, MD,a Nichole Baker, RVT,a John Rectenwald, MD,a Jon L. Eliason, MD,a
Enrique Criado-Pallares, MD,a and Gilbert R. Upchurch Jr, MD,a,b Ann Arbor, Mich; and Charlottesville, Va
Introduction: Although the natural history and management of infected open abdominal aortic aneurysm (AAA) repair is
well described, only sporadic case reports have described the fate of patients with infected endografts placed in the
abdominal aorta. The present study describes a tertiary referral center’s experience with infected endovascular aneurysm
repairs (EVARs).
Methods: The medical records of 1302 open and endovascular aortic procedures were queried from January 2000 to
January 2010. The cases were reviewed for prior aortic procedures, prosthetic implants, and etiology of current open
procedure. Demographics, operative details, and perioperative courses were documented.
Results: Nine patients (1 woman) with a mean age of 71 years had an EVAR that later required an open procedure for
explantation and surgical revision for suspected infection. All grafts were explanted through a midline transperitoneal
approach, with a mean time to explant of 33 months. The explanted endografts included 4 Zenith (Cook, Bloomington,
Ind), 2 Ancure (Endovascular Technologies, Menlo Park, Calif), 2 Excluders (Gore, Flagstaff, Ariz), and 1 AneuRx
(Medtronic, Minneapolis, Minn). Eight of the nine original EVARs were performed at other hospitals; 1 patient had
EVAR and open explant at the University of Michigan. All patients had preoperative computed tomography scans, except
one who was transferred in extremis with a gastrointestinal hemorrhage. Three patients also had a tagged leukocyte scan,
and two had magnetic resonance imaging to further reinforce the suspicion of infection before explantation and bypass
planning. Rifampin-soaked Hemashield (Boston Scientific) in situ grafts were used in four patients, with extra-anatomic
(axillary-bifemoral) bypass used in the other five. The in situ group had no positive preoperative or postoperative cultures,
with the exception of the unstable patient who died the day of surgery. For the other five patients, positive tissue cultures
were found for Bacteroides, Escherichia coli, coagulase-negative Staphylococcus, Streptococcus, and Candida. Three patients
were found to have aortic-enteric fistula, two of whom died before discharge from the hospital. The remaining seven
survived to discharge. Average length of stay was 22 days, with a median follow-up of 11 months.
Conclusion: This series of infected EVARs is the largest group of infected AAA endografts reported to date. Because
EVAR of AAAs is presently the most common method of repair, development of endograft infection, while rare, can be
managed with acceptable mortality rates. Patients presenting with aortic-enteric fistula after EVAR appear to have a more
virulent course. ( J Vasc Surg 2011;54:58-63.)
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to 0.7%,1 but represents a challenging management prob-
lem in aortic surgery. The incidence seems to be similar to
aortic graft infection after open abdominal aortic aneurysm
(AAA) repair, with a predictable high risk of death. Al-
though much attention has been given to the more com-
mon problem of endoleak management, there is still much
to learn about the late complication of endograft infection.
This study evaluated the experience at a tertiary referral
center in managing endograft infections after AAA repair.
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This was a retrospective, single-institution review.
edical records of the 1302 open and endovascular aortic
rocedures performed at University of Michigan were que-
ied from January 2000 to January 2010. The cases were
dentified using Current Procedural Terminology code
5907 and for prior aortic procedures, prosthetic implants,
nd etiology of current open procedure. We identified
ine patients who underwent open aortic endograft ex-
lantation for a suspected infection. Demographics, op-
rative details, culture results, and perioperative courses
ere documented. Any patients with identified aortic
ndograft infection managed medically were not in-
luded in this study design. The Institutional Review
oard at University of Michigan reviewed and approved
his study (#HUM00035996).
ESULTS
Eight of the nine identified patients were men with a
ean age of 71 years (range, 54-84 years). Eight of nine
nitial endovascular aneurysm repairs (EVARs) were per-
ormed at outside institutions (patient 5 had both proce-
ures at University of Michigan). The endografts placed
ncluded 4 Zenith (Cook, Bloomington, Ind), 2 Ancure
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Volume 54, Number 1 Laser et al 59(Endovascular Technologies,Menlo Park, Calif), 2 Exclud-
ers (Gore, Flagstaff, Ariz), and 1 AneuRx (Medtronic,
Minneapolis, Minn; Table). Mean time to endograft ex-
plant was 33 months (range, 6-80 months).
Presentation of aortic graft infection is described in the
literature in one of three typical ways: gastrointestinal (GI)
hemorrhage, chronic low-grade sepsis, or severe sepsis. All
of the patients in this study had one or more of these except
patient 2, who was diagnosed at a follow-up computed
tomography (CT) scan only. Seven patients presented with
clinical manifestations of sepsis, one of which was severe.
Patient 11 had nagging back and pelvic pain with
associated abdominal fullness (in the setting of an enlarging
AAA with no evidence of endoleak). Patient 3 had fever,
chills, and night sweats for approximately 1 month. This
patient presented with fever of 102.4°F, but no other signs
of severe sepsis.
Patient 4 presented with fevers and was found to have a
psoas abscess on CT scan. This was illuminated as a frank
abscess in the terminal aorta during explant. A sigmoid
mass was discovered as well, and perforated diverticulitis
diagnosed. Patient 5 had severe sepsis and presented to the
emergency department with mental status changes, hypo-
tension, leukocytosis, anemia, and complaints of abdominal
pain.
Patient 6 presented with multiple infections, including
a groin infection leading to bacteremia, a septic ankle, and
osteomyelitis of the lumbar and sacral spine. He had been
on chronic antibiotics for the 6 months between implant
and explant. Signs of chronic sepsis were also present in the
last two patients. Patient 8 presented with 1.5 years of back
pain, 6 months of abdominal pain, weight loss, and fevers
up to 101°F. A new heterogenous fluid collection was
found adjacent to the juxtarenal aorta seen on CT. Patient
9 presented with severe back pain radiating down her leg
and fever of 103°F, her third episode of bacteremia in the
prior year.
Other global risk factors such as comorbidities and
smoking status were also evaluated. Patients 8 and 9 were
current smokers and patients 2, 3, 4, and 5 were former
smokers all with40 pack-years each. Patients 1 and 4were
obese, and the rest were at or below the normal weight
Table. Nine patients managed operatively for aortic endog
Patient Age, years Sex Initial endo
1 77 M Zenith
2 67 M Zenith
3 73 M Zenith
4 68 M AneuRx
5 75 M Exclude
6 73 M Ancure
7 84 M Ancure
8 54 M Exclude
9 66 F Zenith
ABFB, Axillary bifemoral bypass; CT, computed tomography; Dapto, dapto
RSHG, rifampin-soaked Hemashield graft; Staph, Staphylococcus; Strep, Strerange. Only patient 5 had documented diabetes. No other smmunosuppressive factors were identified in any of the
ther patients, such as steroid use or chemotherapy.
Endoleaks with subsequent endovascular procedures
ere present in two patients. Patient 1 had a type III leak
ue to poor apposition of the left iliac limb. He underwent
mbolization of the main left hypogastric artery on two
ccasions (coils, and then pushable cores) before explant
ater the same year. No antibiotics were given during this
rocedure. Patient 4 had a type II leak, with six attempts at
mbolization of various arteries, including the right ilio-
umbar and branches of the right hypogastric. Intravenous
ntibiotics were initiated only after the last revision when a
soas abscess was discovered. In patient 2, a type III
ndoleak was identified at the time of infection diagnosis.
Patient 7 presented with a GI hemorrhage and was later
iscovered to have an aortic-enteric fistula (AEF). This
atient had presented to another emergency department
ith GI bleeding two weeks before arrival at our facility.
ndoscopy was done at that time, with biopsy of the
uodenum. The cause of bleeding was not identified, and
he patient was discharged. He then presented to our
nstitution in extremis, having been intubated and received
even units of packed red blood cells in route. In addition to
his patient, AEFs were also discovered in patients 3 and 9.
hey did not present with GI bleeding. The AEFs were
iscovered at explantation only after axillary-bifemoral by-
ass was completed. Patients 3 and 7 experienced excessive
perative bleeding and were not expected to survive. They
ere packed, closed, and transported to the intensive care
nit, where they died within hours. Patient 3 was in hem-
rrhagic shock due to an unidentified source of bleeding
nd cardiac arrested several times intraoperatively. Patient 7
ecame extremely coagulopathic despite resuscitation, and
he family agreed to withdraw care.
In general, workup for diagnosis of graft infection
aried slightly by patient. CT was common to all patients
xcept patient 7 due to his emergent status (Fig 1). Radio-
raphic interpretations such as “multiple foci of gas” and
adjacent fluid collection” were suggestive of aortic en-
ograft infection. Patients 1, 4, and 9 underwent tagged
eukocyte scans to confirm suspicion of infection noted on
T; uptake was visualized in the aortic lumen, “aneurysm
infection after endovascular aneurysm repair
Intervening procedures Interval, months
Endoleak 37
28
20
Endoleak; abscess drained 41
15
Groin, I & D, fem-pop 6
24
Abscess drained 45
Endoleak 80
; GI, gastrointestinal; I & D, incision and drainage; Meropen, meropenem;
us; UTI, urinary tract infection; Vanc, vancomycin.raft
graft
r
r
mycinac adjacent to endograft,” and fluid collection anterior to
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July 201160 Laser et althe iliac bifurcation, respectively. MRI was the confirma-
tory test for patients 6 and 8, elucidating lytic changes of
adjacent vertebral bodies (Fig 2). Operative findings de-
scribed as “frank purulence” or “infected-appearing throm-
bus” were visual confirmation of an infectious nature in six
patients. The remaining two had “inflammatory reactions”
seen in the AEF cases.
All grafts were explanted through a midline transperi-
toneal approach because this is the preferred approach of
the senior author. Total excision of the endograft was
performed in all cases, often using a suprarenal or suprace-
liac clamp, except in patient 2 secondary to overall poor
medical condition and wanting to avoid a suprarenal aortic
cross clamp. An axillary-to-bifemoral bypass was done be-
fore explantation in patients 3, 4, 5, 6, and 9, whereas the
other four underwent simultaneous in situ graft placement.
The axillary-to-bifemoral bypasses were performed with
Fig 1. Computed tomography without contrast of patient 5
shows air in the abdominal aortic aneurysm sac (arrow).
Table. Continued.
Clinical symptoms Antibiotics before resection Diagnosti
Back pain None CT; WBC
None None CT
Fever, chills IV Zosyn, Vanc 6 weeks CT
Fever, abscess Ceftriaxone 4 weeks CT; WBC
Back pain, UTI Zosyn 1 weeks CT
Multiple infections Unknown 6 months CT; MRA
Acute GI bleed None Endoscop
Back pain fever, chills Meropen, Dapto 1 week CT; MRI
Back, leg pain Nafcillin 2 weeks CT; WBCpolytetrafluoroethylene the day before explants, except on rhe same day in patient 6. In situ grafts were rifampin-
oakedHemashield (Boston Scientific Corp) in three of the
atients; the last was patient 7 who exsanguinated due to
isseminated intravascular coagulation immediately after
lacement of a graft.
Complications during the operative procedure in-
luded significant hypotension requiring cardiopulmonary
esuscitation in patient 3 after finding an AEF during
xplantation of the endograft. A sigmoid mass was found in
atient 4, and a colostomy was performed for diverticulitis.
atient 5 was taken back to the operating room later in the
ay for explantation for hypotension and bleeding from an
nternal iliac artery as a result of a calcium plaque going
hrough the front wall.
Antibiotics were given to many of the patients before
ig 2. T1-weighted axial magnetic resonance imaging from pa-
ient 8 demonstrates a focal defect in the anterior vertebral body
arrow) indicating contiguous spread from aortic graft infection
arrowhead).
OR cultures Treatments Follow-up
Negative RSHG Alive; 8 months
Negative RSHG Alive; 6 months
Bacteroides, Candida ABFB Dead
Negative ABFB Alive; 21 months
E. coli ABFB Alive; 21 months
Staph ABFB Alive; 3 months
Bacteroides, E. coli, Strep In situ graft Dead
Negative RSHG Alive; 7 months
Staph, E. coli ABFB Alive; 2 monthsc tests
scan
scan
y
scanesection of the endograft (Table). Patient 3 had been on
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Volume 54, Number 1 Laser et al 61intravenous and then oral antibiotics for 3 months before
graft explantation. Patients 4 and 8 had been on intrave-
nous antibiotics for 1 to 4 weeks due to local abscesses and
patients 5 and 9 for treating suspected remote infections.
Patient 6 also underwent treatment for remote infections
for the entire 6 months between EVAR and graft explanta-
tion. Although preoperative antibiotics can influence intra-
operative culture results, our series did not demonstrate a
clear pattern between presence or length of preoperative
antibiosis and intraoperative culture results.
Results of graft or perigraft fluid cultures at the explant
operation are reported in the Table. Four patients had
negative cultures from graft and aortic material, all of
whom had “frank pus” described at explantation. An in situ
graft had already been decided and started for three of these
patients; patient 4 was given an axillary-to-bifemoral by-
pass. Of the patients with positive cultures, two had puru-
lence or infected-appearing thrombus; the other two were
described as having inflammatory reaction only. Four of
five of this group of patients underwent axillary bifemoral
bypasses. From the thrombus and endograft, gram-positive
coagulase-negative Staphylococcus or Streptococcus spp were
cultured in three patients. Gram-negative bacteria (Bacte-
roides and Escherichia coli) were grown in four patients.
One patient also had a positive fungal culture (Candida
glabrata). Both patients who died had positive cultures for
gram-negative bacteria.
All surviving patients received broad-spectrum antibi-
otics until bacterial culture identification allowed for re-
placement by selective antibiotic regimen for 4 to 6 weeks
after discharge. Patients were monitored by the Infectious
Disease Service, and of the surviving patients, five have
records that indicate they are being maintained on lifelong
oral antibiotics. Interestingly, patient 4 required replace-
ment for a septic knee approximately 20 months after
explantation.
AEFs are rare and difficult to manage. Patient 3 had a
large 4-cm defect found in the aortic wall and fourth part of
the duodenum. The aneurysm of patient 7 appeared to
have mucosa directly eroded into it. The duodenum of
patient 9 was found densely adherent to the aneurysm sac
by the retroperitoneal abscess. The exact cause of fistula
formation is not known, but is hypothesized to be due to
erosion of the graft fabric into the duodenum. What role
stents or hooks have on this process (ie, namely with aortic
pseudoaneurysm formation) would be purely speculative.
Two of the patients found to have AEFs died before
discharge from the hospital. The remaining seven patients
survived to discharge with an average length of stay of 22
days (range, 9-55 days). Mean follow-up of the surviving
patients was 11 months (range, 3-21 months).
DISCUSSION
Several studies have suggested a similar incidence of
aortic graft infections in open and endovascular cases.1-3
Open aortic graft infections have been well documented in
the literature; however, endovascular graft infections have
been reported only in case reports and small series totaling g10 patients.1,4,5 This therefore is the largest single-insti-
ution case series known to date of graft infections after
VARs.
The largest studies of open AAA graft infections show
ortic graft infections presenting close to 2 to 5 years after
mplantation.6,7 More recent data showed that aortic graft
nfections (open and endovascular) occurred most com-
only in the first year after surgery. This is possibly due to
mproved imaging reducing the time to diagnosis.1,2 We
ound that the average time to explants for this series of
ndografts was substantially longer, at 33 months. One
ossible explanation is patients being lost to follow-up or
ransferring care from the institution that performed the
riginal procedure.
Endovascular aortic stent graft infections have been
hown to present roughly one-third as chronic sepsis, one-
hird as severe acute sepsis, and one-third as AEFs.1,4,8
ymptoms are important, and were present in eight of nine
atients in this study. Many patient complaints and symp-
oms were vague and relatively nonspecific, as has been
escribed previously,9 leading to a delay in the correct
iagnosis. Current follow-up guidelines for EVAR recom-
end periodic CT scans (yearly) and therefore may enable
ore rapid identification of gas or fluid that can spur
nvestigation of suspicions for infection. Nonoperative
reatment exists as an option for selected patients present-
ng with infected endograft after EVAR. This is primarily
eserved for patients who cannot tolerate an open surgical
rocedure, because mortality rates of 36% have been re-
orted.4 These patients are usually managed with percuta-
eous drainage, instillation of antibiotics through drains,
nd intravenous antibiotics for at least 6 weeks.
The cause of aortic graft infections in general, and
pecifically endograft infections, has been hypothesized.
ogel et al2 concluded in 2008 in a population level
nalysis that aortic graft infections were associated with
eriprocedural infections for both endovascular and open
AA repairs.2 Unfortunately, due to the retrospective na-
ure of our study and the fact that most initial procedures
ere at outside hospitals, complete periprocedural data for
he original EVARs are not available for this study.
Although experimental data have shown that endovas-
ular devices offer less bacterial resistance and increased
dherence8,10 than grafts placed during open surgery, some
tudies have shown similar rates of aortic graft infections
etween open and endovascular approaches to AAA re-
air.2,3 EVAR largely eliminates the contamination associ-
ted with placement due to sterile sheaths and delivery
ystems. Contrary to this, however, are studies that show
ecreased sterility in endografts placed in interventional
uites compared with traditional operating theaters.4,11
hese effects may balance out and produce equal rates of
ortic graft infections in open and endovascular cases. If
ndografts are placed in operating room or sterile endovas-
ular suites, then the sources of infection must arise from
lsewhere. Data appear to point to a hematogenous source
f secondary bacterial seeding of endografts causing aortic
raft infections. In six of nine patients in this study, there
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identified to support this hypothesis. However, it is difficult
to determine causality because the time course is unclear.
Other sources of infection include perioperative contami-
nation, mechanical erosion (stent migration, excessive an-
gulation) leading to AEF, aortic thrombus as a nidus, or
contamination from additional procedures (for endoleaks).
Identified sources in this group include multiple inter-
vening endovascular procedures in two patients (patients 1
and 4) and immediate preceding or concurrent presenta-
tion of remote infections in four patients. Patient 5 had
pneumonia 2 months prior and a urinary tract infection at
admission, patient 6 had groin infection, spinal osteomyeli-
tis, and a septic ankle diagnosed before explantation, pa-
tient 8 had a retroperitoneal perispinal abscess drained 2
Fig 3. Proposed algorithm for workup and managem
aneurysm repair. CT, Computed tomography; GI, gastromonths before presentation, and patient 9 had a urinary sract infection, with the first of three episodes of bacteremia
tarting 1 year before presenting. Possible sources for infec-
ion of the aortic endograft may be that the original AAA in
atient 2 was ruptured and an increased bacterial load could
ave been introduced during the emergent procedure (op-
rative records unavailable). In addition, the AAAs done
mergently could have been mycotic in nature. Patient 3
ad an open repair for aortic occlusive disease 11 years
efore an endovascular repair for a proximal anastomotic
seudoaneurysm, which was 12.5 years before the en-
ograft explantation. The pseudoaneurysm was suspicious
or the presence of an infection at that time.
The literature has shown that positive cultures are not
lways found in cases of suspected endograft infection. The
illing-Smith group1 reported only 68% of cases demon-
f patients with infected endograft after endovascular
tinal.ent otrated a positive culture. Three of four patients in our in
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cultures, despite the appearance of frank purulence. The
exception is patient 7, who was too unstable to consider
alternative surgical management and died the day of sur-
gery. Correspondingly, four of five patients managed with
an axillary-to-bifemoral bypass had positive intraoperative
graft or tissue cultures. Patient 4 did not, but had a positive
culture for Streptococcus from his psoas abscess earlier in the
hospital course. This is a small sample size, but begs inquiry
and investigation into decision making for management of
infected aortic endografts. The presence of frank purulence
did not necessarily correspond with positive OR cultures. It
would be helpful to have a way of knowing preoperatively
which cases would have positive cultures and decide for an
extra-anatomic bypass to decrease bacterial spread.
The few surgeons who performed these endograft re-
sections and revascularizations were not following a preset
guideline, but made independent decisions on a patient-by-
patient basis. Looking retrospectively at this series of pa-
tients, and understanding that culture data are not always
available before operative decisions are made, a proposed
algorithm to manage patients presenting with a suspected
infected endograft after EVAR is found in Fig 3. It suggests
that when blood or abscess cultures are positive, an extra-
anatomic reconstruction and graft resection is preferable.
In contrast, when all obtainable preoperative cultures are
negative, an in situ graft placement after resection is sug-
gested.
The most common culture reported in the literature
has been gram-positive bacteria, with the specific bacterial
organism Staphylococcus spp representing 23% to 88% of all
positive cultures.1,3,5,12 Our study did not support this and
unexpectedly had more gram-negative bacterial cultures
than positive. Also in opposition to previously reported
literature, Candida glabrata was present in one of four
patients with positive cultures. These could reflect local
bacterial patterns and virulences, or simply a small study
size.
Limitations of this study include a possible exclusion
bias as a result of a limited coding scheme. Short follow-up
time is noted, due to most of the procedures being within
the last 2 years of included time period. Bias may also be
present due to the single-institution, referral nature of this
study.
Further studies are needed to identify patients at great-
est risk for infection, which would necessitate enhanced
surveillance, longer treatment of intervening infections, or
prophylactic antibiotic treatment before any invasive pro-
cedures attempting to preserve the original endograft. This
will be difficult to accomplish due to the low incidence of
infected EVARs. SONCLUSIONS
This experience with infected EVARs contributes to
he body of literature currently available largely in the form
f case reports. Infection of an endograft after EVAR, like
hat after open AAA repair, is rare, difficult to manage, and
otentially lethal. There are multiple presenting symptoms
ssociated with endograft infection, but the presence of an
EF increases the virulence of a patient’s course. Further
nvestigation into the role of culture positivity in manage-
ent decisions is required.
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